PHARMORUBICIN PFS DIN 02065703
Health Canada record
| Active ingredient(s) | EPIRUBICIN HYDROCHLORIDE 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01DB03 EPIRUBICIN |
| Original market date | 31-Dec-1995 |
| Current status date | 04-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPIRUBICIN HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02413221 | EPIRUBICIN HYDROCHLORIDE INJECTION | STRIDES PHARMA CANADA INC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Approved |
| 02322242 | EPIRUBICIN HYDROCHLORIDE INJECTION | UMAN PHARMA INC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Approved |
| 02324091 | EPIRUBICIN HYDROCHLORIDE INJECTION | TEVA CANADA LIMITED | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Marketed |
| 02409372 | EPIRUBICIN HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Approved |
| 02301067 | EPIRUBICIN HYDROCHLORIDE FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | EPIRUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02303892 | EPIRUBICIN HYDROCHLORIDE INJECTION | ACCORD HEALTHCARE INC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02312093 | EPIRUBICIN HYDROCHLORIDE INJECTION | FRESENIUS KABI CANADA LTD | Solution | EPIRUBICIN HYDROCHLORIDE 2.0 MG | Dormant |
| 02323001 | EPIRUBICIN HYDROCHLORIDE INJECTION | PHARMACEUTICAL PARTNERS OF CANADA INC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Cancelled Pre Market |
| 02264927 | EPIRUBICIN HYDROCHLORIDE INJECTION | PFIZER CANADA ULC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02387379 | EPIRUBICIN HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Cancelled Pre Market |
| 02065746 | PHARMORUBICIN RDF | PFIZER CANADA ULC | Powder For Solution | EPIRUBICIN HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02069512 | PHARMORUBICIN RDF | PFIZER CANADA ULC | Powder For Solution | EPIRUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 00640069 | PHARMORUBICIN RDF INJ 50MG/VIAL | ADRIA LABORATORIES OF CANADA LTD. | Powder For Solution | EPIRUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02410400 | PMS-EPIRUBICIN | PHARMASCIENCE INC | Solution | EPIRUBICIN HYDROCHLORIDE 2 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19144 | 2017-04-10 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 533 | 2003-09-11 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2232 | 2001-04-12 | New Drug Submission (NDS) | NEW MANUFACTURER NAME |
| 3759 | 1997-05-29 | New Drug Submission (NDS) | |
| 5796 | 1994-01-12 | New Drug Submission (NDS) |
International API supply for EPIRUBICIN HYDROCHLORIDE
7 valid EDQM Certificates of Suitability from 7 holders. 7 active FDA Drug Master Files.
Request a quote for PHARMORUBICIN PFS